Cardiac Biotech CBSC Stock
Cardiac Biotech Price Chart
Cardiac Biotech CBSC Financial and Trading Overview
Cardiac Biotech stock price | 0.03 USD |
Previous Close | 0.17 USD |
Open | 0.17 USD |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.17 - 0.17 USD |
52 Week Range | 0.12 - 0.3 USD |
Volume | 27.8K USD |
Avg. Volume | 28.32K USD |
Market Cap | 20.92M USD |
Beta (5Y Monthly) | 0.614084 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
CBSC Valuation Measures
Enterprise Value | 9.94M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 415.23944 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 197.279 |
Enterprise Value/EBITDA | -13.872 |
Trading Information
Cardiac Biotech Stock Price History
Beta (5Y Monthly) | 0.614084 |
52-Week Change | 16.43% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.3 USD |
52 Week Low | 0.12 USD |
50-Day Moving Average | 0.15 USD |
200-Day Moving Average | 0.17 USD |
CBSC Share Statistics
Avg. Volume (3 month) | 28.32K USD |
Avg. Daily Volume (10-Days) | 44.27K USD |
Shares Outstanding | 123.03M |
Float | N/A |
Short Ratio | N/A |
% Held by Insiders | N/A |
% Held by Institutions | N/A |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2018 |
Most Recent Quarter (mrq) | March 31, 2018 |
Next Fiscal Year End | March 31, 2019 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -1485.99% |
Gross Margin | 54.34% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | N/A |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 50.37K USD |
Revenue Per Share (ttm) | 0.001 USD |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | 23.49K USD |
EBITDA | -716355 USD |
Net Income Avi to Common (ttm) | -640547 USD |
Diluted EPS (ttm) | -0.02 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 4.67K USD |
Total Cash Per Share (mrq) | 0 USD |
Total Debt (mrq) | 0 USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.029 |
Book Value Per Share (mrq) | -0.024 |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of Cardiac Biotech
Country | United States |
State | NV |
City | Las Vegas |
Address | 10845 Griffith Peak Drive |
ZIP | 89135 |
Phone | 888-225-0870 |
Website | https://cbscientificinc.com |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 5 |
CB Scientific, Inc., through its subsidiaries, provides various products and services in the ambulatory non-invasive cardiac monitoring space in the United States and internationally. Its EKG devices, interactive cloud-based acquisition software, and smartphone apps provide improved compliance for patients at risk of abnormal heart rhythms, as well as accurate information for physicians. The company is based in Las Vegas, Nevada.
Q&A For Cardiac Biotech Stock
What is a current CBSC stock price?
Cardiac Biotech CBSC stock price today per share is 0.03 USD.
How to purchase Cardiac Biotech stock?
You can buy CBSC shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cardiac Biotech?
The stock symbol or ticker of Cardiac Biotech is CBSC.
Which industry does the Cardiac Biotech company belong to?
The Cardiac Biotech industry is Medical Instruments & Supplies.
How many shares does Cardiac Biotech have in circulation?
The max supply of Cardiac Biotech shares is 161.37M.
What is Cardiac Biotech Price to Earnings Ratio (PE Ratio)?
Cardiac Biotech PE Ratio is now.
What was Cardiac Biotech earnings per share over the trailing 12 months (TTM)?
Cardiac Biotech EPS is 0 USD over the trailing 12 months.
Which sector does the Cardiac Biotech company belong to?
The Cardiac Biotech sector is Healthcare.